proton pump inhibitors - HEALTHIES
ascopubs.org: Proton pump inhibitors and the risk of adverse renal events and all-cause mortality in cancer patients receiving immune checkpoint inhibitors. Proton pump inhibitors and the risk of adverse renal events and all-cause mortality in cancer patients receiving immune checkpoint inhibitors. The long term use of proton pump inhibitors (PPIs), a class of drugs widely used to treat acid reflux and ulcers, may not be linked to any increased risk of developing gastric (stomach) cancer, finds ...
Understanding the Context
Dr Punam Krishan explained everything to people taking proton pump inhibitors (PPIs) like omeprazole for heartburn, acid reflux, and indigestion ... Since their development and widespread adoption in the late 1980s, proton pump inhibitors (PPI) have transformed the field of gastroenterology. Their high efficacy and favorable safety profiles have ... Nearly 70% of patients with acute upper gastrointestinal (GI) bleeding and low-risk or no peptic ulcer disease received intravenous (IV) proton pump inhibitors (PPIs) inappropriately, leading to ...
Image Gallery
Key Insights
News Medical: Study challenges link between proton pump inhibitors and kidney disease risk A recent Scientific Reports study investigates whether the association between proton pump inhibitors (PPIs) and the use of histamine-2 receptor antagonists (H2RA) affects the risk of chronic kidney ... News Medical: Long-term proton pump inhibitor use not linked to stomach cancer